TY - JOUR AU - Hardy, J. A. AU - Higgins, G. A. PY - 1992 DA - 1992// TI - Alzheimer’s disease: the amyloid cascade hypothesis JO - Science VL - 256 UR - https://doi.org/10.1126/science.1566067 DO - 10.1126/science.1566067 ID - Hardy1992 ER - TY - JOUR AU - Hyman, B. T. PY - 2012 DA - 2012// TI - National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease JO - Alzheimers Dement VL - 8 UR - https://doi.org/10.1016/j.jalz.2011.10.007 DO - 10.1016/j.jalz.2011.10.007 ID - Hyman2012 ER - TY - JOUR AU - Leinonen, V. PY - 2010 DA - 2010// TI - Amyloid and tau proteins in cortical brain biopsy and Alzheimer’s disease JO - Ann Neurol VL - 68 UR - https://doi.org/10.1002/ana.22100 DO - 10.1002/ana.22100 ID - Leinonen2010 ER - TY - JOUR AU - Aprahamian, I. AU - Stella, F. AU - Forlenza, O. V. PY - 2013 DA - 2013// TI - New treatment strategies for Alzheimer’s disease: is there a hope? JO - Indian J Med Res VL - 138 ID - Aprahamian2013 ER - TY - JOUR AU - Wang, C. Y. PY - 2017 DA - 2017// TI - UB-311, a novel UBITh((R)) amyloid beta peptide vaccine for mild Alzheimer’s disease JO - Alzheimers Dement (N Y) VL - 3 UR - https://doi.org/10.1016/j.trci.2017.03.005 DO - 10.1016/j.trci.2017.03.005 ID - Wang2017 ER - TY - JOUR AU - Cummings, J. AU - Lee, G. AU - Mortsdorf, T. AU - Ritter, A. AU - Zhong, K. PY - 2017 DA - 2017// TI - Alzheimer’s disease drug development pipeline: 2017 JO - Alzheimers Dement (N Y) VL - 3 UR - https://doi.org/10.1016/j.trci.2017.05.002 DO - 10.1016/j.trci.2017.05.002 ID - Cummings2017 ER - TY - JOUR AU - Lannfelt, L. PY - 2014 DA - 2014// TI - Perspectives on future Alzheimer therapies: amyloid-beta protofibrils - a new target for immunotherapy with BAN2401 in Alzheimer’s disease JO - Alzheimers Res Ther VL - 6 UR - https://doi.org/10.1186/alzrt246 DO - 10.1186/alzrt246 ID - Lannfelt2014 ER - TY - JOUR AU - Coric, V. PY - 2015 DA - 2015// TI - Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial JO - JAMA Neurol VL - 72 UR - https://doi.org/10.1001/jamaneurol.2015.0607 DO - 10.1001/jamaneurol.2015.0607 ID - Coric2015 ER - TY - JOUR AU - Sevigny, J. PY - 2016 DA - 2016// TI - The antibody aducanumab reduces Abeta plaques in Alzheimer’s disease JO - Nature VL - 537 UR - https://doi.org/10.1038/nature19323 DO - 10.1038/nature19323 ID - Sevigny2016 ER - TY - JOUR AU - McKhann, G. M. PY - 2011 DA - 2011// TI - The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease JO - Alzheimers Dement VL - 7 UR - https://doi.org/10.1016/j.jalz.2011.03.005 DO - 10.1016/j.jalz.2011.03.005 ID - McKhann2011 ER - TY - JOUR AU - Dubois, B. PY - 2014 DA - 2014// TI - Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria JO - Lancet Neurol VL - 13 UR - https://doi.org/10.1016/s1474-4422(14)70090-0 DO - 10.1016/s1474-4422(14)70090-0 ID - Dubois2014 ER - TY - JOUR AU - Clark, C. M. PY - 2011 DA - 2011// TI - Use of florbetapir-PET for imaging beta-amyloid pathology JO - Jama VL - 305 UR - https://doi.org/10.1001/jama.2010.2008 DO - 10.1001/jama.2010.2008 ID - Clark2011 ER - TY - JOUR AU - Weston, P. S. PY - 2016 DA - 2016// TI - Diagnosing dementia in the clinical setting: can amyloid PET provide additional value over cerebrospinal fluid? JO - J Alzheimers Dis VL - 54 UR - https://doi.org/10.3233/jad-160302 DO - 10.3233/jad-160302 ID - Weston2016 ER - TY - JOUR AU - Ben Bouallegue, F. AU - Mariano-Goulart, D. AU - Payoux, P. PY - 2017 DA - 2017// TI - Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database JO - Alzheimers Res Ther VL - 9 UR - https://doi.org/10.1186/s13195-017-0260-z DO - 10.1186/s13195-017-0260-z ID - Ben Bouallegue2017 ER - TY - JOUR AU - Tapiola, T. PY - 2009 DA - 2009// TI - Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain JO - Arch Neurol VL - 66 UR - https://doi.org/10.1001/archneurol.2008.596 DO - 10.1001/archneurol.2008.596 ID - Tapiola2009 ER - TY - JOUR AU - Andreasen, N. PY - 1999 DA - 1999// TI - Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease JO - Arch Neurol VL - 56 UR - https://doi.org/10.1001/archneur.56.6.673 DO - 10.1001/archneur.56.6.673 ID - Andreasen1999 ER - TY - JOUR AU - Holtta, M. PY - 2013 DA - 2013// TI - Evaluating amyloid-beta oligomers in cerebrospinal fluid as a biomarker for Alzheimer’s disease JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0066381 DO - 10.1371/journal.pone.0066381 ID - Holtta2013 ER - TY - JOUR AU - Blennow, K. AU - Mattsson, N. AU - Scholl, M. AU - Hansson, O. AU - Zetterberg, H. PY - 2015 DA - 2015// TI - Amyloid biomarkers in Alzheimer’s disease JO - Trends Pharmacol Sci VL - 36 UR - https://doi.org/10.1016/j.tips.2015.03.002 DO - 10.1016/j.tips.2015.03.002 ID - Blennow2015 ER - TY - JOUR AU - Landau, S. M. PY - 2013 DA - 2013// TI - Comparing positron emission tomography imaging and cerebrospinal fluid measurements of beta-amyloid JO - Ann Neurol VL - 74 UR - https://doi.org/10.1002/ana.23908 DO - 10.1002/ana.23908 ID - Landau2013 ER - TY - JOUR AU - Hake, A. PY - 2015 DA - 2015// TI - Florbetapir positron emission tomography and cerebrospinal fluid biomarkers JO - Alzheimers Dement VL - 11 UR - https://doi.org/10.1016/j.jalz.2015.03.002 DO - 10.1016/j.jalz.2015.03.002 ID - Hake2015 ER - TY - JOUR AU - Roberts, K. F. PY - 2014 DA - 2014// TI - Amyloid-beta efflux from the central nervous system into the plasma JO - Ann Neurol VL - 76 UR - https://doi.org/10.1002/ana.24270 DO - 10.1002/ana.24270 ID - Roberts2014 ER - TY - JOUR AU - Hampel, H. PY - 2018 DA - 2018// TI - Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic JO - Nat Rev Neurol VL - 14 UR - https://doi.org/10.1038/s41582-018-0079-7 DO - 10.1038/s41582-018-0079-7 ID - Hampel2018 ER - TY - JOUR AU - Yang, C. C. PY - 2011 DA - 2011// TI - Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer’s disease in vitro JO - ACS Chem Neurosci VL - 2 UR - https://doi.org/10.1021/cn200028j DO - 10.1021/cn200028j ID - Yang2011 ER - TY - JOUR AU - Yang, S. Y. AU - Chieh, J. J. AU - Yang, C. C. AU - Liao, S. H. AU - Chen, H. H. AU - Horng, H. E. AU - Yang, H. C. AU - Hong, C. Y. AU - Chiu, M. J. AU - Chen, T. F. AU - Huang, K. W. AU - Wu, C. C. PY - 2013 DA - 2013// TI - Clinic Applications in Assaying Ultra-Low-Concentration Bio-Markers Using HTS SQUID-Based AC Magnetosusceptometer JO - IEEE Transactions on Applied Superconductivity VL - 23 UR - https://doi.org/10.1109/TASC.2012.2229772 DO - 10.1109/TASC.2012.2229772 ID - Yang2013 ER - TY - JOUR AU - Chiu, M. J. PY - 2013 DA - 2013// TI - Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer’s disease JO - ACS Chem Neurosci VL - 4 UR - https://doi.org/10.1021/cn400129p DO - 10.1021/cn400129p ID - Chiu2013 ER - TY - JOUR AU - Yang, S. Y. AU - Chiu, M. J. AU - Chen, T. F. AU - Horng, H. E. PY - 2017 DA - 2017// TI - Detection of plasma biomarkers using Immunomagnetic reduction: a promising method for the early diagnosis of Alzheimer’s disease JO - Neurol Ther VL - 6 UR - https://doi.org/10.1007/s40120-017-0075-7 DO - 10.1007/s40120-017-0075-7 ID - Yang2017 ER - TY - JOUR AU - Lue, L. F. PY - 2017 DA - 2017// TI - Plasma levels of Abeta42 and tau identified probable Alzheimer’s dementia: findings in two cohorts JO - Front Aging Neurosci VL - 9 UR - https://doi.org/10.3389/fnagi.2017.00226 DO - 10.3389/fnagi.2017.00226 ID - Lue2017 ER - TY - JOUR AU - Tzen, K. Y. PY - 2014 DA - 2014// TI - Plasma Abeta but not tau is related to brain PiB retention in early Alzheimer’s disease JO - ACS Chem Neurosci VL - 5 UR - https://doi.org/10.1021/cn500101j DO - 10.1021/cn500101j ID - Tzen2014 ER - TY - JOUR AU - Bu, G. PY - 2009 DA - 2009// TI - Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy JO - Nat Rev Neurosci VL - 10 UR - https://doi.org/10.1038/nrn2620 DO - 10.1038/nrn2620 ID - Bu2009 ER - TY - JOUR AU - Kim, J. AU - Basak, J. M. AU - Holtzman, D. M. PY - 2009 DA - 2009// TI - The role of apolipoprotein E in Alzheimer’s disease JO - Neuron VL - 63 UR - https://doi.org/10.1016/j.neuron.2009.06.026 DO - 10.1016/j.neuron.2009.06.026 ID - Kim2009 ER - TY - JOUR AU - Yu, J. T. AU - Tan, L. AU - Hardy, J. PY - 2014 DA - 2014// TI - Apolipoprotein E in Alzheimer’s disease: an update JO - Annu Rev Neurosci VL - 37 UR - https://doi.org/10.1146/annurev-neuro-071013-014300 DO - 10.1146/annurev-neuro-071013-014300 ID - Yu2014 ER - TY - JOUR AU - Bales, K. R. PY - 1997 DA - 1997// TI - Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition JO - Nat Genet VL - 17 UR - https://doi.org/10.1038/ng1197-263 DO - 10.1038/ng1197-263 ID - Bales1997 ER - TY - JOUR AU - Irizarry, M. C. PY - 2000 DA - 2000// TI - Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background JO - Ann N Y Acad Sci VL - 920 UR - https://doi.org/10.1111/j.1749-6632.2000.tb06919.x DO - 10.1111/j.1749-6632.2000.tb06919.x ID - Irizarry2000 ER - TY - JOUR AU - Kanekiyo, T. AU - Xu, H. AU - Bu, G. PY - 2014 DA - 2014// TI - ApoE and Abeta in Alzheimer’s disease: accidental encounters or partners? JO - Neuron VL - 81 UR - https://doi.org/10.1016/j.neuron.2014.01.045 DO - 10.1016/j.neuron.2014.01.045 ID - Kanekiyo2014 ER - TY - JOUR AU - Namba, Y. AU - Tomonaga, M. AU - Kawasaki, H. AU - Otomo, E. AU - Ikeda, K. PY - 1991 DA - 1991// TI - Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease JO - Brain Res VL - 541 UR - https://doi.org/10.1016/0006-8993(91)91092-F DO - 10.1016/0006-8993(91)91092-F ID - Namba1991 ER - TY - JOUR AU - Risacher, S. L. PY - 2013 DA - 2013// TI - The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI) JO - Front Aging Neurosci VL - 5 UR - https://doi.org/10.3389/fnagi.2013.00011 DO - 10.3389/fnagi.2013.00011 ID - Risacher2013 ER - TY - JOUR AU - Johnson, K. A. PY - 2013 DA - 2013// TI - Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer’s disease dementia, mild cognitive impairment, and normal aging JO - Alzheimers Dement VL - 9 UR - https://doi.org/10.1016/j.jalz.2012.10.007 DO - 10.1016/j.jalz.2012.10.007 ID - Johnson2013 ER - TY - JOUR AU - Lin, K. J. PY - 2010 DA - 2010// TI - Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study JO - Nucl Med Biol VL - 37 UR - https://doi.org/10.1016/j.nucmedbio.2010.02.003 DO - 10.1016/j.nucmedbio.2010.02.003 ID - Lin2010 ER - TY - JOUR AU - Hsiao, I. T. PY - 2013 DA - 2013// TI - Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET JO - Eur J Nucl Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-013-2350-x DO - 10.1007/s00259-013-2350-x ID - Hsiao2013 ER - TY - JOUR AU - Emi, M. PY - 1988 DA - 1988// TI - Genotyping and sequence analysis of apolipoprotein E isoforms JO - Genomics VL - 3 UR - https://doi.org/10.1016/0888-7543(88)90130-9 DO - 10.1016/0888-7543(88)90130-9 ID - Emi1988 ER - TY - JOUR AU - Fleisher, A. S. PY - 2011 DA - 2011// TI - Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease JO - Arch Neurol VL - 68 UR - https://doi.org/10.1001/archneurol.2011.150 DO - 10.1001/archneurol.2011.150 ID - Fleisher2011 ER - TY - JOUR AU - Villemagne, V. L. PY - 2011 DA - 2011// TI - Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease JO - Ann Neurol VL - 69 UR - https://doi.org/10.1002/ana.22248 DO - 10.1002/ana.22248 ID - Villemagne2011 ER - TY - JOUR AU - Doraiswamy, P. M. PY - 2012 DA - 2012// TI - Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study JO - Neurology VL - 79 UR - https://doi.org/10.1212/WNL.0b013e3182661f74 DO - 10.1212/WNL.0b013e3182661f74 ID - Doraiswamy2012 ER - TY - JOUR AU - Drzezga, A. PY - 2009 DA - 2009// TI - Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease JO - Neurology VL - 72 UR - https://doi.org/10.1212/WNL.0b013e3181a2e8d0 DO - 10.1212/WNL.0b013e3181a2e8d0 ID - Drzezga2009 ER - TY - JOUR AU - Morris, J. C. PY - 2010 DA - 2010// TI - APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging JO - Ann Neurol VL - 67 UR - https://doi.org/10.1002/ana.21843 DO - 10.1002/ana.21843 ID - Morris2010 ER - TY - JOUR AU - Liu, C. C. AU - Liu, C. C. AU - Kanekiyo, T. AU - Xu, H. AU - Bu, G. PY - 2013 DA - 2013// TI - Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy JO - Nat Rev Neurol VL - 9 UR - https://doi.org/10.1038/nrneurol.2012.263 DO - 10.1038/nrneurol.2012.263 ID - Liu2013 ER - TY - JOUR AU - Ungar, L. AU - Altmann, A. AU - Greicius, M. D. PY - 2014 DA - 2014// TI - Apolipoprotein E, gender, and Alzheimer’s disease: an overlooked, but potent and promising interaction JO - Brain Imaging Behav VL - 8 UR - https://doi.org/10.1007/s11682-013-9272-x DO - 10.1007/s11682-013-9272-x ID - Ungar2014 ER - TY - JOUR AU - Ovod, V. PY - 2017 DA - 2017// TI - Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2017.06.2266 DO - 10.1016/j.jalz.2017.06.2266 ID - Ovod2017 ER - TY - JOUR AU - Nakamura, A. PY - 2018 DA - 2018// TI - High performance plasma amyloid-beta biomarkers for Alzheimer’s disease JO - Nature VL - 554 UR - https://doi.org/10.1038/nature25456 DO - 10.1038/nature25456 ID - Nakamura2018 ER - TY - JOUR AU - Toledo, J. B. PY - 2015 DA - 2015// TI - Nonlinear association between cerebrospinal fluid and florbetapir F-18 beta-amyloid measures across the spectrum of Alzheimer disease JO - JAMA Neurol VL - 72 UR - https://doi.org/10.1001/jamaneurol.2014.4829 DO - 10.1001/jamaneurol.2014.4829 ID - Toledo2015 ER -